Labcorp to acquire Personal Genome Diagnostics in $575m worth deal

Labcorp to acquire Personal Genome Diagnostics in $575m worth deal

Labcorp, a North Carolina-based life sciences company, has agreed to acquire Personal Genome Diagnostics (PGDx), a provider of liquid biopsy and tissue-based genomic products and services, in a deal worth up to $575 million. According to Labcorp, the Maryland-based Personal Genome Diagnostics alongside its technology complements and expedites its existing liquid biopsy capabilities and grows […]

Quantix SCS acquires bulk transportation services firm Delaware Express

Quantix SCS acquires bulk transportation services firm Delaware Express

Quantix SCS, a Texas-based supply chain services company, has acquired Delaware Express Co., a provider of dry and liquid bulk transportation services, for an undisclosed price. Delaware Express is a regional trucking company based in Elkton, Maryland. Established in 1935, the family-owned has four additional satellite terminals located across Delaware, New York, New Jersey, and […]

ALTIVIA sells water treatment chemical business to USALCO

ALTIVIA sells water treatment chemical business to USALCO

ALTIVIA, a Texas-based chemical manufacturer, has divested its water treatment chemical business to USALCO, a portfolio company of global alternative assets investment firm H.I.G. Capital. The financial terms of the deal were not disclosed. The water treatment business involved in the deal includes ferric and ferrous sulfate production facilities in Houston. J. Michael Jusbasche — […]

Amwins acquires Maryland-based general agent M.T. Donahoe & Associates

Amwins acquires Maryland-based general agent M.T. Donahoe & Associates

Amwins, a US-based specialty insurance products and services distributor, has acquired CBIZ M.T. Donahoe & Associates (MTDA), a Maryland-based general agent, which specializes in employee and individual benefits and services. The financial terms of the deal were not disclosed. Becky Patel – CEO of Amwins Connect said: “We’re excited to welcome Mike and the entire […]

Automated data governance company Immuta secures $90m in Series D

Automated data governance company Immuta secures $90m in Series D

Immuta, a provider of automated data governance with a cloud native platform, announced that it has raised $90 million in Series D funding led by new investor Greenspring Associates. The Maryland-based start-up said that the capital will be used for strengthening its market leadership position and take control of the increasing demand for centralized, scalable […]

Sun Life Financial health care advisory firm PinnacleCare for $85m

Sun Life Financial health care advisory firm PinnacleCare for $85m

Sun Life Financial has agreed to acquire US medical intelligence and health care navigation provider Pinnacle Care International (PinnacleCare) for $85 million. The Canadian financial services company said that the acquisition of the personal health care advisory solutions provider will expand its stop-loss and health business in the US. PinnacleCare, which is based in Maryland, […]

Hilb Group acquires P&C consulting firm Parallel Risk Advisors

Hilb Group acquires P&C consulting firm Parallel Risk Advisors

The Hilb Group (THG), a Virginia-based property and casualty and employee benefits insurance brokerage and advisory company, has acquired Parallel Risk Advisors (PRA) based in Maryland for an undisclosed price. Parallel Risk Advisors is a commercial lines property and casualty (P&C) consulting and advisory company. It specializes in the commercial real estate sector. Debbie Dorsch […]

Cellphire Therapeutics raises $15m in Series A funding round

Cellphire Therapeutics raises $15m in Series A funding round

Cellphire Therapeutics, a Maryland-based biotech company focused on the long-term stabilization and storage of platelets, has raised $15 million in a Series A funding round. The financing round was led by Simcah Management. Currently, Cellphire Therapeutics is set to take its two products – Thrombosomes and Cryopreserved Platelets (CPP) in two phase 2 clinical trials […]